✦ LIBER ✦

A response to “Clinical Trials in Lung Cancer: Truth, Justice, and the American Way”: Reply

✍ Scribed by Richard H Feins

Book ID: 117033796
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 129 KB
Volume: 72
Category: Article
ISSN: 0003-4975
DOI: 10.1016/s0003-4975(01)02879-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A response to “Clinical Trials in Lung C

A response to “Clinical Trials in Lung Cancer: Truth, Justice, and the American Way”

✍ Frederic W Grannis Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Clinical trials in lung cancer: Truth, J

Clinical trials in lung cancer: Truth, Justice, and the American Way

✍ Richard H Feins 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Non-overlapping American College of Rheu

Non-overlapping American College of Rheumatology response rates: A better way to report response in rheumatoid arthritis Clinical Trials

✍ Maarten Boers; Piet J. Kostense 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Lung cancer classification: The relation

Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population

✍ Clifton F. Mountain; John M. Lukeman; Samuel P. Hammar; Dean W. Chamberlain; Wal 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

Correlation of in vitro drug-sensitivity

Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Barriers to the participation of African

Barriers to the participation of African-American patients with cancer in clinical trials : A pilot study

✍ Anjali S. Advani; Benjamin Atkeson; Carrie L. Brown; Bercedis L. Peterson; Laura 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: African-american patients have been under-represented in oncology clinical trials. better understanding barriers to african-american participation may help increase the accrual of african-american patients onto clinical trials. ## Methods: Two hundred eighteen patients with maligna